Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078355311> ?p ?o ?g. }
- W2078355311 endingPage "e287" @default.
- W2078355311 startingPage "e287" @default.
- W2078355311 abstract "Background Obesity is associated with low-grade chronic inflammation, and serum markers of inflammation are independent risk factors for cardiovascular disease (CVD). However, the molecular and cellular mechanisms that link obesity to chronic inflammation and CVD are poorly understood. Methods and Findings Acute-phase serum amyloid A (A-SAA) mRNA levels, and A-SAA adipose secretion and serum levels were measured in obese and nonobese individuals, obese participants who underwent weight-loss, and persons treated with the insulin sensitizer rosiglitazone. Inflammation-eliciting activity of A-SAA was investigated in human adipose stromal vascular cells, coronary vascular endothelial cells and a murine monocyte cell line. We demonstrate that A-SAA was highly and selectively expressed in human adipocytes. Moreover, A-SAA mRNA levels and A-SAA secretion from adipose tissue were significantly correlated with body mass index ( r = 0.47; p = 0.028 and r = 0.80; p = 0.0002, respectively). Serum A-SAA levels decreased significantly after weight loss in obese participants ( p = 0.006), as well as in those treated with rosiglitazone ( p = 0.033). The magnitude of the improvement in insulin sensitivity after weight loss was significantly correlated with decreases in serum A-SAA ( r = −0.74; p = 0.034). SAA treatment of vascular endothelial cells and monocytes markedly increased the production of inflammatory cytokines, e.g., interleukin (IL)-6, IL-8, tumor necrosis factor alpha, and monocyte chemoattractant protein-1. In addition, SAA increased basal lipolysis in adipose tissue culture by 47%. Conclusions A-SAA is a proinflammatory and lipolytic adipokine in humans. The increased expression of A-SAA by adipocytes in obesity suggests that it may play a critical role in local and systemic inflammation and free fatty acid production and could be a direct link between obesity and its comorbidities, such as insulin resistance and atherosclerosis. Accordingly, improvements in systemic inflammation and insulin resistance with weight loss and rosiglitazone therapy may in part be mediated by decreases in adipocyte A-SAA production." @default.
- W2078355311 created "2016-06-24" @default.
- W2078355311 creator A5007408007 @default.
- W2078355311 creator A5011090035 @default.
- W2078355311 creator A5021669286 @default.
- W2078355311 creator A5024158146 @default.
- W2078355311 creator A5033223907 @default.
- W2078355311 creator A5039855940 @default.
- W2078355311 creator A5045894434 @default.
- W2078355311 creator A5052801519 @default.
- W2078355311 creator A5057209268 @default.
- W2078355311 creator A5063028007 @default.
- W2078355311 creator A5063305111 @default.
- W2078355311 creator A5075191109 @default.
- W2078355311 creator A5075306031 @default.
- W2078355311 creator A5088938586 @default.
- W2078355311 date "2006-06-06" @default.
- W2078355311 modified "2023-10-02" @default.
- W2078355311 title "Acute-Phase Serum Amyloid A: An Inflammatory Adipokine and Potential Link between Obesity and Its Metabolic Complications" @default.
- W2078355311 cites W1534360145 @default.
- W2078355311 cites W1633340712 @default.
- W2078355311 cites W1639924204 @default.
- W2078355311 cites W1656068683 @default.
- W2078355311 cites W1974599416 @default.
- W2078355311 cites W1974654697 @default.
- W2078355311 cites W1978047273 @default.
- W2078355311 cites W1981851376 @default.
- W2078355311 cites W1984057531 @default.
- W2078355311 cites W1986349550 @default.
- W2078355311 cites W1990588947 @default.
- W2078355311 cites W1991401793 @default.
- W2078355311 cites W2003025916 @default.
- W2078355311 cites W2003230730 @default.
- W2078355311 cites W2005262235 @default.
- W2078355311 cites W2005838261 @default.
- W2078355311 cites W2014113220 @default.
- W2078355311 cites W2014663082 @default.
- W2078355311 cites W2029629731 @default.
- W2078355311 cites W2029954109 @default.
- W2078355311 cites W2031805664 @default.
- W2078355311 cites W2032310689 @default.
- W2078355311 cites W2033202132 @default.
- W2078355311 cites W2046165350 @default.
- W2078355311 cites W2050330440 @default.
- W2078355311 cites W2055619124 @default.
- W2078355311 cites W2058428175 @default.
- W2078355311 cites W2058610272 @default.
- W2078355311 cites W2060899732 @default.
- W2078355311 cites W2061089980 @default.
- W2078355311 cites W2063207755 @default.
- W2078355311 cites W2065364777 @default.
- W2078355311 cites W2070619903 @default.
- W2078355311 cites W2087706636 @default.
- W2078355311 cites W2103602099 @default.
- W2078355311 cites W2107940713 @default.
- W2078355311 cites W2110826760 @default.
- W2078355311 cites W2115335486 @default.
- W2078355311 cites W2118154631 @default.
- W2078355311 cites W2129316761 @default.
- W2078355311 cites W2133032991 @default.
- W2078355311 cites W2146321139 @default.
- W2078355311 cites W2146845495 @default.
- W2078355311 cites W2159406914 @default.
- W2078355311 cites W2159886947 @default.
- W2078355311 cites W2160563455 @default.
- W2078355311 cites W2163092745 @default.
- W2078355311 cites W2169614683 @default.
- W2078355311 cites W2172692903 @default.
- W2078355311 cites W2317184793 @default.
- W2078355311 cites W2320010944 @default.
- W2078355311 cites W2329406962 @default.
- W2078355311 cites W2343078807 @default.
- W2078355311 cites W4230870013 @default.
- W2078355311 cites W4238497443 @default.
- W2078355311 cites W4249727000 @default.
- W2078355311 doi "https://doi.org/10.1371/journal.pmed.0030287" @default.
- W2078355311 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1472697" @default.
- W2078355311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16737350" @default.
- W2078355311 hasPublicationYear "2006" @default.
- W2078355311 type Work @default.
- W2078355311 sameAs 2078355311 @default.
- W2078355311 citedByCount "301" @default.
- W2078355311 countsByYear W20783553112012 @default.
- W2078355311 countsByYear W20783553112013 @default.
- W2078355311 countsByYear W20783553112014 @default.
- W2078355311 countsByYear W20783553112015 @default.
- W2078355311 countsByYear W20783553112016 @default.
- W2078355311 countsByYear W20783553112017 @default.
- W2078355311 countsByYear W20783553112018 @default.
- W2078355311 countsByYear W20783553112019 @default.
- W2078355311 countsByYear W20783553112020 @default.
- W2078355311 countsByYear W20783553112021 @default.
- W2078355311 countsByYear W20783553112022 @default.
- W2078355311 countsByYear W20783553112023 @default.
- W2078355311 crossrefType "journal-article" @default.
- W2078355311 hasAuthorship W2078355311A5007408007 @default.
- W2078355311 hasAuthorship W2078355311A5011090035 @default.
- W2078355311 hasAuthorship W2078355311A5021669286 @default.